FDA Drug Application (021217) for EXALGO by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number021217
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXALGO
Active IngredientHYDROMORPHONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROMORPHONE HYDROCHLORIDE5


Back to FDA Applications sponsored by MALLINCKRODT INC